Literature DB >> 32271695

CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis.

Jijian Sun1, Shijie Pan1, Hongquan Cui1, Hao Li1.   

Abstract

BACKGROUND: Emerging studies have indicated that circular RNAs (circRNAs) play important roles in the development of many tumors. CircRNA-scavenger receptor class B member 1 (Circ-SCARB1) was consistently reported as an elevated circRNA in RCC tissues. This study focused on examining the biological function and molecular mechanism of circSCARB1 in RCC progression.
METHODS: Expressions of Circ-SCARB1, microRNA (miR)-510-5p, and syndecan 3 (SDC3) were detected using a quantitative real-time polymerase chain reaction (RT-PCR) and/or western blot. Cell proliferation and apoptosis were measured by 3-(4, 5)-dimethylthiahiazo (-z-y1)-3, 5-diphenytetrazoliumromide and flow cytometry, respectively. Cell migration and invasion were measured using Transwell assays. The interaction between miR-510-5p and Circ-SCARB1 or SDC3 was verified using dual-luciferase reporter assays.
RESULTS: Circ-SCARB1 was elevated in 30 pairs of RCC tissues and multiple RCC cell lines. Knockdown of Circ-SCARB1 inhibited cell proliferation, migration, and invasion while inducing cell apoptosis. MiR-510-5p was confirmed to be a target of Circ-SCARB1; inhibition of cell progression by silencing Circ-SCARB1 was mediated by a direct interaction between Circ-SCARB1 and miR-510-5p. SDC3 was verified to be a gene target of miR-510-5p; transfection of miR-510-5p mimic not only suppressed the expression of SDC3 but also the cell proliferation and an SDC3 cotransfection partially restored cell proliferation. Additionally, the genetic knockdown of Circ- SCARB1 reduced the expression SDC3, and the addition of anti-miR-510-5p could partially reelevate SDC3 expression.
CONCLUSION: Circ-SCARB1 promotes RCC progression via sequestering miR-510-5p and indirectly up-regulating SDC3 expression. This provides a novel perspective for the pathogenesis of RCC and potential therapeutic targets for the treatment of RCC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Circ-SCARB1; RCC cell lines; SDC3; miR-510-5p; progression; renal cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32271695     DOI: 10.2174/1568009620666200409130032

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  9 in total

Review 1.  The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma.

Authors:  Hui Huang; Tao Chen; Fei Li; Dan Jin; Chuan Li; Yongbo Yang; Xuyang Liu; Dongmiao Wang; Jiehui Di
Journal:  Med Oncol       Date:  2022-05-15       Impact factor: 3.064

Review 2.  Use of Circular RNAs in Diagnosis, Prognosis and Therapeutics of Renal Cell Carcinoma.

Authors:  Rebeca Osca-Verdegal; Jesús Beltrán-García; José Luis Górriz; José María Martínez Jabaloyas; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Cell Dev Biol       Date:  2022-06-22

3.  Circ-ELF2 Acts as a Competing Endogenous RNA to Facilitate Glioma Cell Proliferation and Aggressiveness by Targeting MiR-510-5p/MUC15 Signaling.

Authors:  Weixin Zhang; ChunMiao Xu; Jianyu Guo; Limei Guo; Hongliang Huo; Huan Wang
Journal:  Onco Targets Ther       Date:  2020-10-09       Impact factor: 4.147

4.  LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells.

Authors:  Biqi Wang; Duo Tang; Zijia Liu; Qian Wang; Shan Xue; Zijie Zhao; Dongdong Feng; Chao Sheng; Jintao Li; Zhixiang Zhou
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

5.  CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma.

Authors:  Lisa Frey; Niklas Klümper; Doris Schmidt; Glen Kristiansen; Marieta Toma; Manuel Ritter; Abdullah Alajati; Jörg Ellinger
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

Review 6.  Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.

Authors:  Sina Rashedi; Mahta Mardani; Ali Rafati; Mohammad Mahdi Khavandi; Fatemeh Mohammadi; Salar Javanshir; Rojin Sarallah; Mahsa Dolatshahi; Mohammadmahdi Sabahi; Sina Azadnajafabad; Hamed Tavolinejad; Nima Rezaei
Journal:  J Clin Lab Anal       Date:  2022-08-21       Impact factor: 3.124

7.  Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment.

Authors:  Endika Prieto-Fernández; Leire Egia-Mendikute; Alexandre Bosch; Ana García Del Río; Borja Jimenez-Lasheras; Asier Antoñana-Vildosola; So Young Lee; Asis Palazon
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

8.  LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA.

Authors:  Yi Ding; Xiangyu Tan; Abuduyilimu Abasi; Yun Dai; Ruxing Wu; Tao Zhang; Kexin Li; Miao Yan; Xiaoyuan Huang
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

9.  The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1.

Authors:  Shuo Zhu; Shengya Cao; Weibin Yang; Jinhui Che; Deqiang Li; Ruifeng Pei; Yiren Ding
Journal:  Cancer Manag Res       Date:  2021-07-16       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.